Reducing Off-Label Antipsychotic Use in Older Community-Dwelling Adults With Dementia: A Narrative Review. Review uri icon

Overview

abstract

  • The off-label use of antipsychotics for the management of behavioral and psychologic symptoms of dementia (BPSD) in older adults (age ≥65 years) is common, despite evidence of modest benefits and serious risks. Although national initiatives aimed at reducing antipsychotic use among older adults with BPSD in nursing homes have been successful, similar initiatives are lacking for community-dwelling adults with dementia. As a result, older adults with BPSD residing in the community may be at an even greater risk of being negatively affected by antipsychotic use. Physicians should be knowledgeable of this issue and understand the alternatives to antipsychotics, as well as how to reduce antipsychotic use in patients with dementia who are already taking antipsychotics.

publication date

  • July 1, 2017

Research

keywords

  • Antipsychotic Agents
  • Dementia
  • Off-Label Use

Identity

Scopus Document Identifier

  • 85021423170

Digital Object Identifier (DOI)

  • 10.7556/jaoa.2017.090

PubMed ID

  • 28662557

Additional Document Info

volume

  • 117

issue

  • 7